欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PT/H/2252/002
药品名称
Imatinib Zentiva
活性成分
IMATINIB MESILATE 478.0 mg
剂型
Film-coated tablet
上市许可持有人
Zentiva Portugal, Lda.
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
Germany (DE)
Imaitnin Zentiva 100 mg Filmtabletten
United Kingdom (Northern Ireland) (XI)
France (FR)
Estonia (EE)
Poland (PL)
Imatinib Zentiva
Romania (RO)
Imatinib Zentiva 400 mg comprimate filmate
许可日期
2012/11/15
最近更新日期
2023/03/22
药物ATC编码
L01XE01 imatinib
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final PL
|
uk-combined
Date of last change:2016/07/21
Final SPC
|
SmPC 400 mg
Date of last change:2016/05/27
Final Labelling
|
Labelling 400 mg
Date of last change:2016/05/27
Final Product Information
|
Imatinib 100+400 mg fct NL-H-2542 EPAR_DL response 141128cl
Date of last change:2015/01/26
PAR
|
PAR_2542_dc_imatinib_21 aug 2013
Date of last change:2013/09/17
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase